ArticleJHEP reports : innovation in hepatology2024

MZF1 promotes tumour progression and resistance to anti-PD-L1 antibody treatment in hepatocellular carcinoma.

Anna Kan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.